|
|
Cetrotide - Newsfeeds
-
-
The slow market growth is attributed to the patent expiry of the branded products such as Cetrotide and Ovidrel in 2015. Some key branded products, such as Cetrotide, GONAL-f, Crinone, Ovidrel, Luveris, Pergoveris ...
-
-
s portfolio of fertility treatments is Cetrotide® (cetrorelix acetate for injection) used to control certain hormonal surges. The Senior Medical Director, US Medical Affairs, in this position will assist in development ...
-
-
Quebec-based Aeterna markets a hormone medication for in vitro fertilization procedures called Cetrotide. Apr 05, 2010 Retail stocks rise on pending home sales, ISM data , MarketWatch.com Retail stocks rise after better-than-anticipated pending home ...
-
-
s portfolio of fertility treatments is Cetrotide® (cetrorelix acetate for injection) used to control certain hormonal surges. The Medical Director, US Medical Affairs, in this position will assist in development, conducts and directs the activities ...
-
-
Quebec-based Aeterna markets a hormone medication for in vitro fertilization procedures called Cetrotide.
-
-
Additionally, sales volumes of Cetrotide(R) were lower during the three-month period ended September 30, 2009, compared to the same period in 2008. Consolidated research and development ("R&D") costs, net of tax credits and grants, were $9.7 million ...
-
-
Additionally, sales volumes of Cetrotide were lower during the three-month period ended September 30, 2009, compared to the same period in 2008. Consolidated research and development ("R&D") costs, net of tax credits and grants , were $9.7 million ...
-
-
... decline in sales volumes of fertility drug Cetrotide, and lower royalty revenues in connection with the monetization of the royalties derived from the company's agreement with Merck Serono. Sales and royalties for the third quarter slid to $5.54 ...
-
-
25th: Started a new injection tonight, Cetrotide. This is now taken along with the other two injections and the tablets. Again, it's straightforward to mix and administer and I am not bruising. I think it could be because I am now more relaxed about ...
-
-
- December - Sale of AEterna Zentaris rights to royalties on future sales of Cetrotide(R), covered by the Company's license agreement with Merck Serono, to Cowen Healthcare Royalty Partners L.P. ("Cowen") for gross consideration of $52.5 million ...
-
-
Cetrorelix acetate is marketed under the brand name Cetrotide , the first LHRH antagonist approved for therapeutic use as part of in vitro fertilization programs (controlled ovulation stimulation/assisted reproductive technologies) in Europe, the USA ...
-
-
Cetrorelix acetate is marketed under the brand name Cetrotide , the first LHRH antagonist approved for therapeutic use as part of in vitro fertilization programs (controlled ovulation stimulation/assisted reproductive technologies) in Europe, the USA ...
-
-
... division primarily offers various prescription drugs, including Erbitux for metastatic colorectal, head, and neck cancer; UFT for colorectal cancer; Rebif for multiple sclerosis; Gonal-f Ovitrelle Pergoveris, Luveris, Crinone, and Cetrotide ...
-
-
As a result, Judith M. Layzer will obtain coverage from her Part D plan of Cetrotide, a hormone treatment costing upwards of $35,000 per month, which has been shown effective against ovarian cancer, with minimal toxicity, in a study in the journal ...
-
-
The company also markets Cetrorelix for in vitro fertilization under the brand name, Cetrotide. Its lead oncology compound consists of AEZS-108, a cytotoxic peptide conjugate, which is a hybrid molecule composed of a synthetic peptide carrier and a ...
-
-
Cetrorelix acetate is marketed under the brand name Cetrotide(R), the first LHRH antagonist approved for therapeutic use as part of in vitro fertilization programs (controlled ovulation stimulation/assisted reproductive technologies) in Europe, the ...
-
-
Cetrorelix acetate is marketed under the brand name Cetrotide(R), the first LHRH antagonist approved for therapeutic use as part of in vitro fertilization programs (controlled ovulation stimulation/assisted reproductive technologies) in Europe, the ...
-
-
Cetrorelix acetate is marketed under the brand name Cetrotide(R), the first LHRH antagonist approved for therapeutic use as part of in vitro fertilization programs (controlled ovulation stimulation/assisted reproductive technologies) in Europe ...
Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.
|
|
